In hepatoblastoma (HB), SLC7A1, as a substrate of the tumor suppressor gene SPOP, affects the progression of HB by regulating arginine metabolism, thus providing a new therapeutic target for HB [13]. Here, SLC7A1 is linked to hemoglobin measurement.